“The fluoropyrimidine agents such as 5-Fluorouracil (5-FU) and capecitabine , widely used to treat gastrointestinal, breast, head and neck cancers, either as a single agent or in combination with other chemotherapies, can cause potentially lethal cardiac side effects.”